Page last updated: 2024-08-24

aripiprazole and Autism

aripiprazole has been researched along with Autism in 34 studies

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (23.53)29.6817
2010's22 (64.71)24.3611
2020's4 (11.76)2.80

Authors

AuthorsStudies
Pierce, DL; Smith, JR1
Naguy, A; Naguy, C1
Alamiri, B; Hasan, AE; Jamali, MA; Naguy, A; Pridmore, S1
Aboul-Fotouh, S; El-Salam, MFA; Elayat, WM; Elhossiny, RM; Habib, MZ; Hassan, GAM; Mohamad, MI; Zohny, SM1
Fatima, S; Mottola, N1
Tang, J; Xie, Q; Xu, Y; Zeng, HL1
Berk, M; Ghanizadeh, A; Sahraeizadeh, A1
Forbes, RA; Mankoski, R; Manos, G; Marcus, R; Marler, S; McQuade, R; Stockton, G1
Anagnostou, E; Baribeau, DA1
Amatniek, J; Eudicone, JM; Findling, RL; Lears, K; Mankoski, R; Marcus, RN; McCartney, T; McQuade, RD; Sheehan, JJ; Timko, K1
Adler, BA; Early, M; Erickson, CA; McDougle, CJ; Minshawi, N; Shaffer, R; Wink, LK1
Bent, S; Hendren, RL1
Karakurt, MN; Süren, S1
Ghanizadeh, A; Jaafari, N; Tordjman, S1
DeFilippis, M; Wagner, KD1
Sanchack, KE; Thomas, CA1
Erickson, CA; McDougle, CJ; Posey, DJ; Stigler, KA1
Cosenza, A; Masi, G; Millepiedi, S; Muratori, F; Pari, C; Salvadori, F1
De León, OA; Garza, VM; Shepherd, J1
Aman, MG; Carson, WH; Kamen, L; Manos, G; Marcus, RN; McQuade, RD; Owen, R1
Carson, WH; Corey-Lisle, P; Findling, RL; Manos, G; Marcus, RN; McQuade, RD; Owen, R; Sikich, L1
Aman, MG; Kasper, W; Mankoski, R; Manos, G; Marcus, R; Mathew, S; Owen, R1
Gialloreti, LE; Guida, S; Pardini, M1
Aman, MG; Farmer, CA1
Curran, MP2
Aman, MG; Carson, WH; Corey-Lisle, PK; Kamen, L; Mankoski, R; Manos, G; Marcus, RN; McQuade, RD; Owen, R1
Carson, WH; Findling, RL; Kamen, L; Mankoski, R; Manos, G; Marcus, RN; McQuade, RD; Owen, R1
Ammerman, DK; Carson, WH; Corey-Lisle, PK; Guo, Z; Handen, BL; Mankoski, R; Manos, G; Marcus, RN; Mathew, S; McQuade, RD; Owen, R; Varni, JW1
Kirino, E1
Eisenstein, M1
Tsai, SJ1
Alla, L; Sabaratnam, M; Shastri, M1
Demb, H; Valicenti-McDermott, MR1

Reviews

8 review(s) available for aripiprazole and Autism

ArticleYear
An update on medication management of behavioral disorders in autism.
    Current psychiatry reports, 2014, Volume: 16, Issue:3

    Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Autistic Disorder; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Humans; Piperazines; Propylamines; Quinolones; Risperidone

2014
Complementary and alternative treatments for autism part 1: evidence-supported treatments.
    AMA journal of ethics, 2015, Apr-01, Volume: 17, Issue:4

    Topics: Acetylcysteine; Animals; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Complementary Therapies; Disease Models, Animal; Evidence-Based Medicine; Free Radical Scavengers; Gastrointestinal Tract; Humans; Inflammation; Mice; Oxidative Stress; Randomized Controlled Trials as Topic; Risperidone; United States; United States Food and Drug Administration; Vitamin B 12

2015
Aripiprazole for treating irritability in children & adolescents with autism: A systematic review.
    The Indian journal of medical research, 2015, Volume: 142, Issue:3

    Topics: Adolescent; Aripiprazole; Autistic Disorder; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Randomized Controlled Trials as Topic

2015
Autism Spectrum Disorder: Primary Care Principles.
    American family physician, 2016, Dec-15, Volume: 94, Issue:12

    Topics: Antipsychotic Agents; Aripiprazole; Asperger Syndrome; Autism Spectrum Disorder; Autistic Disorder; Behavior Therapy; Child Development Disorders, Pervasive; Child, Preschool; Early Diagnosis; Early Medical Intervention; Humans; Infant; Primary Health Care; Referral and Consultation; Risperidone

2016
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
    The Journal of clinical psychiatry, 2008, Volume: 69 Suppl 4

    Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Benzodiazepines; Child; Child Development Disorders, Pervasive; Child, Preschool; Clozapine; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles

2008
Aripiprazole for the treatment of irritability associated with autism.
    Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:4

    Topics: Antipsychotic Agents; Aripiprazole; Autistic Disorder; Humans; Irritable Mood; Piperazines; Quinolones; Risperidone

2011
Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients.
    Paediatric drugs, 2011, Jun-01, Volume: 13, Issue:3

    Topics: Aripiprazole; Autistic Disorder; Child; Clinical Trials as Topic; Drug Dosage Calculations; Humans; Irritable Mood; Piperazines; Quinolones; Time Factors

2011
Efficacy and safety of aripiprazole in child and adolescent patients.
    European child & adolescent psychiatry, 2012, Volume: 21, Issue:7

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Bipolar Disorder; Child; Humans; Piperazines; Quinolones; Schizophrenia

2012

Trials

8 trial(s) available for aripiprazole and Autism

ArticleYear
A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial.
    Child psychiatry and human development, 2014, Volume: 45, Issue:2

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones; Risperidone; Treatment Outcome

2014
Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change.
    Journal of child and adolescent psychopharmacology, 2013, Volume: 23, Issue:8

    Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Body Weight; Child; Double-Blind Method; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones

2013
A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.
    The Journal of clinical psychiatry, 2014, Volume: 75, Issue:1

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Double-Blind Method; Drug Administration Schedule; Female; Humans; Irritable Mood; Kaplan-Meier Estimate; Long-Term Care; Male; Piperazines; Placebos; Quinolones; Secondary Prevention; Treatment Outcome

2014
A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2009, Volume: 48, Issue:11

    Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Irritable Mood; Male; Personality Assessment; Piperazines; Psychomotor Agitation; Quinolones; Self-Injurious Behavior; Treatment Outcome

2009
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
    Pediatrics, 2009, Volume: 124, Issue:6

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Irritable Mood; Male; Personality Assessment; Piperazines; Quinolones; Treatment Outcome; Weight Gain

2009
Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.
    Journal of child and adolescent psychopharmacology, 2010, Volume: 20, Issue:5

    Topics: Adolescent; Affective Symptoms; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Checklist; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Irritable Mood; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Self-Injurious Behavior; Treatment Outcome

2010
Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.
    Journal of child and adolescent psychopharmacology, 2011, Volume: 21, Issue:3

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Female; Follow-Up Studies; Humans; Irritable Mood; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome

2011
Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
    The Journal of clinical psychiatry, 2011, Volume: 72, Issue:9

    Topics: Adolescent; Aggression; Alanine Transaminase; Antipsychotic Agents; Aripiprazole; Aspartate Aminotransferases; Autistic Disorder; Basal Ganglia Diseases; Child; Drug Tolerance; Female; Humans; Irritable Mood; Male; Piperazines; Quinolones; Weight Gain

2011

Other Studies

18 other study(ies) available for aripiprazole and Autism

ArticleYear
    Journal of child and adolescent psychopharmacology, 2022, Volume: 32, Issue:1

    Topics: Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Compulsive Behavior; Humans; Sexual Behavior

2022
Trichotieromania and Alopecia Areata Triggered by Aripiprazole-Methylphenidate Combo in an Autistic Child: The Nexus of Impulsivity-Compulsivity.
    Psychopharmacology bulletin, 2022, 05-31, Volume: 52, Issue:2

    Topics: Alopecia Areata; Aripiprazole; Autistic Disorder; Child; Humans; Impulsive Behavior; Methylphenidate

2022
Agomelatine Monotherapy for Autism-A Case Report.
    Psychopharmacology bulletin, 2022, 10-27, Volume: 52, Issue:4

    Topics: Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Humans; Risperidone

2022
Memantine/Aripiprazole Combination Alleviates Cognitive Dysfunction in Valproic Acid Rat Model of Autism: Hippocampal CREB/BDNF Signaling and Glutamate Homeostasis.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2023, Volume: 20, Issue:2

    Topics: Animals; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Disease Models, Animal; Female; gamma-Aminobutyric Acid; Glutamates; Hippocampus; Homeostasis; Male; Memantine; Pregnancy; Rats; Rats, Wistar; Valproic Acid

2023
Case 5: A 7-year-old Autistic Boy with Altered Movements and Mental Status.
    Pediatrics in review, 2017, Volume: 38, Issue:10

    Topics: Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Dystonia; Humans; Male

2017
[Clinical observation of aripiprazole in the treatment of autism].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2013, Volume: 15, Issue:4

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child, Preschool; Female; Humans; Male; Piperazines; Quinolones

2013
Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
    Autism : the international journal of research and practice, 2015, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Intellectual Disability; Male; Middle Aged; Pilot Projects; Piperazines; Quinolones; Retrospective Studies; Risk Factors; Risperidone; Self-Injurious Behavior; Treatment Failure; Young Adult

2015
Desmopressin Use in the Treatment of Aripiprazole-Induced Nocturnal Enuresis in a Child Diagnosed with Autıstıc Disorder.
    Journal of child and adolescent psychopharmacology, 2015, Volume: 25, Issue:6

    Topics: Antidiuretic Agents; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Deamino Arginine Vasopressin; Humans; Male; Nocturnal Enuresis

2015
Treatment of Autism Spectrum Disorder in Children and Adolescents.
    Psychopharmacology bulletin, 2016, Aug-15, Volume: 46, Issue:2

    Topics: Adolescent; Aripiprazole; Autism Spectrum Disorder; Autistic Disorder; Child; Humans; Irritable Mood; Risperidone; Serotonin Antagonists

2016
Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.
    CNS drugs, 2009, Volume: 23, Issue:6

    Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Chi-Square Distribution; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Retrospective Studies; Severity of Illness Index

2009
Waxing-and-waning catatonia after intermittent exposure to aripiprazole in a case of autism and bipolar disorder.
    Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:5

    Topics: Adult; Aripiprazole; Autistic Disorder; Bipolar Disorder; Catatonia; Humans; Male; Piperazines; Quinolones

2009
Aripiprazole treatment for coprophagia in autistic disorder.
    The Journal of neuropsychiatry and clinical neurosciences, 2010,Fall, Volume: 22, Issue:4

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Human Coprophagia; Humans; Male; Piperazines; Quinolones

2010
Aripiprazole in the treatment of irritability associated with autistic disorder in paediatric patients: profile report.
    CNS drugs, 2011, Sep-01, Volume: 25, Issue:9

    Topics: Adolescent; Aripiprazole; Autistic Disorder; Child; Double-Blind Method; Humans; Irritable Mood; Piperazines; Quinolones; Randomized Controlled Trials as Topic

2011
Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials.
    Clinical therapeutics, 2012, Volume: 34, Issue:4

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Dose-Response Relationship, Drug; Humans; Irritable Mood; Piperazines; Quality of Life; Quinolones; Randomized Controlled Trials as Topic

2012
Treatments: In the waiting room.
    Nature, 2012, Nov-01, Volume: 491, Issue:7422

    Topics: Adolescent; Adult; Animals; Aripiprazole; Autistic Disorder; Brain; Child; Clinical Trials as Topic; Drug Approval; Drug Repositioning; Humans; Oxytocin; Piperazines; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Trichuris; United States; United States Food and Drug Administration

2012
TrkB partial agonists: potential treatment strategy for epilepsy, mania, and autism.
    Medical hypotheses, 2006, Volume: 66, Issue:1

    Topics: Aripiprazole; Autistic Disorder; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Epilepsy; Humans; Piperazines; Quinolones; Receptor, trkB; Signal Transduction

2006
Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:6

    Topics: Adolescent; Aged; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Female; Humans; Intellectual Disability; Male; Mental Disorders; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenia, Paranoid

2006
Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:5

    Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Body Mass Index; Child; Child Behavior Disorders; Child, Preschool; Dose-Response Relationship, Drug; Drug Approval; Female; Follow-Up Studies; Humans; Impulsive Behavior; Intellectual Disability; Male; Mood Disorders; Piperazines; Quinolones; Reactive Attachment Disorder; Self-Injurious Behavior; Sleep Wake Disorders

2006
chemdatabank.com